Joint Corp Stock Price, News & Analysis

The Joint Corp. (NASDAQ: JYNT) announced plans to restate its financial statements for full-year 2024 and Q1 2025 due to errors in calculating impairment charges for clinics held for sale. The restatement is expected to reduce the 2024 net loss by $2.2 million and increase Q1 2025 net income by $0.5 million, resulting in a cumulative $2.7 million increase in the carrying value of assets held for sale.

The company identified a misapplication of accounting guidance related to the valuation methodology for assets held for sale. While the restatement will not impact Adjusted EBITDA, cash positions, or restricted cash for either period, the company expects to report a material weakness in internal control over financial reporting and ineffective disclosure controls.

The Joint Corp. (NASDAQ: JYNT), the largest franchisor of chiropractic care through The Joint Chiropractic network, has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.

The company will host a conference call at 5:00 p.m. EDT featuring President and CEO Sanjiv Razdan and CFO Scott Bowman. Investors can access the call by dialing (833) 630-0823 or (412) 317-1831. A live webcast with slides will be available on the company's IR events page, and an audio archive will be accessible for one week.

The Joint Corp (NASDAQ: JYNT) has completed a significant transaction involving the sale of 31 corporate-owned clinics in Arizona and New Mexico to Joint Ventures, LLC for $8.3 million in cash. As part of the deal, JYNT acquired regional developer rights in the Northwest region, which generated $855,000 in royalties and franchise fees over the 12 months ended March 31, 2025.

The acquired Northwest territory rights cover 46 existing franchised clinics and 30 sites for future development. Joint Ventures, one of JYNT's strongest franchisees, will grow to 96 clinics and has committed to opening 10 additional locations. The company expects this refranchising initiative to strengthen its business model, reduce commission obligations, and increase operating margins.

The Joint Corp. (NASDAQ: JYNT), the nation's largest chiropractic care franchisor, has launched its first official mobile app for iOS and Android platforms. The app introduces several key features to enhance patient experience, including a clinic locator, doctor availability checker, in-clinic check-in using geofencing technology, and push notifications for updates and promotions.

According to CEO Sanjiv Razdan, this technology investment aims to improve access to care and deliver a more seamless connection to their chiropractic services. The app launch follows a successful multi-phase beta test across various locations nationwide, marking a significant milestone in The Joint's commitment to making chiropractic care more accessible, affordable, and convenient.

The Joint Corp. (NASDAQ: JYNT) has announced significant strategic moves to strengthen its position as the largest pure play chiropractic care franchise system. The company has signed a binding agreement to sell 31 corporate clinics in Arizona and New Mexico to Joint Ventures, LLC, its largest franchisee, in exchange for cash and regional developer rights in the Northwest region.

Joint Ventures will increase its clinic count to 96 locations and has committed to opening 10 additional clinics. Additionally, The Joint has refranchised 5 clinics in the Kansas City region to Chiro 93, LLC. The Northwest region acquisition includes 46 existing franchised clinics and 30 sites for future development. These strategic moves aim to improve profitability by reducing regional developer commissions and increasing operating margins.

The Joint Corp (NASDAQ: JYNT), the largest provider of chiropractic care through The Joint Chiropractic network, has appointed Scott J. Bowman as its new Chief Financial Officer, effective June 10, 2025. Bowman, who brings over 30 years of experience in finance across restaurants, retail, and CPG sectors, replaces outgoing CFO Jake Singleton. With experience as CFO at three public companies and one private company, Bowman brings expertise in capital markets, strategic planning, operations, and investor relations. The appointment aligns with The Joint's strategic focus on transformation and growth, as the company aims to become a pure play franchisor and establish itself as America's most accessible health and wellness services company.

The Joint Corp (NASDAQ: JYNT), the largest U.S. chiropractic care provider through The Joint Chiropractic network, has announced a $5 million stock repurchase program starting August 2025. CEO Sanjiv Razdan stated the buyback reflects board confidence in their long-term strategy, refranchising program, and projected cash flow generation. The program, which runs until June 3, 2027, allows for repurchases through open market or private transactions, with timing and amounts determined by the board's finance committee. Management believes the company's franchise model and long-term value are currently undervalued in the stock price.

The Joint Corp (NASDAQ: JYNT), the largest provider of chiropractic care in the US, has appointed Sandi Karrmann as a new Director, expanding its board to eight members. Karrmann brings significant experience as a global HR executive, having served as CHRO at major companies including Kimberly-Clark, Tenet Healthcare, and Yum! Restaurants International. The appointment aligns with The Joint's 2025 strategic priorities focused on strengthening core operations, improving profitability, and reigniting growth. CEO Sanjiv Razdan emphasized that Karrmann's expertise in healthcare and franchising will help enhance talent management, employee engagement, and retention of Doctors of Chiropractic, ultimately aiming to improve patient experience and drive sales growth.

The Joint Corp (NASDAQ: JYNT) reported Q1 2025 financial results, showing revenue growth of 7% to $13.1 million from continuing operations. The company achieved system-wide sales growth of 5% to $132.6 million and comp sales of 3%. However, they reported a net loss from continuing operations of $506,000. During Q1, the company sold 9 franchise licenses, opened 5 franchised clinics, refranchised 2 corporate clinics, and closed 1 corporate clinic, bringing the total clinic count to 969. The company is transitioning to become a pure-play franchisor and implementing new marketing and operational initiatives. For 2025, they maintain guidance of system-wide sales between $550-570 million, mid-single-digit comp sales, and consolidated Adjusted EBITDA of $10.0-11.5 million. They expect 30-40 new franchised clinic openings in 2025.